N/A N=33 InFlux System for Nasal Breathing Improvement
Nasal Airway Obstruction
Primary: Incidence of Unanticipated Serious Adverse Device Effects — 0 events
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=194 Study of the Effect of Chondroitin Sulfate on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI
Knee Osteoarthritis
Primary: Cartilage Volume Loss of the Lateral Compartment — 6408; 6196; 6196; 6143 cubic milimeters
Phase 3 N=666 Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Kidney Transplantation · Chronic Kidney Failure
Primary: Percent of Participants Surviving With a Functioning Graft by Month 12 — 92.8; 96.5; 95.4 percentage of participants
N/A N=1,167 An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy
Anemia
Primary: Change in Hemoglobin (Hb) Level From Baseline to End of Treatment (EOT) — 14.58 g/L — p=<0.0001
Phase 4 N=49 Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis
Anemia, Sickle Cell · Pain
Primary: Change in Pain Score 20 Minutes After Administration of Study Drug — 1; 2 units on a scale — p=0.048
N/A N=46 XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer
Breast Cancer
Primary: Progression-free Survival (PFS) — 9.89 months
Phase 4 N=359 PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain
Cancer
Primary: Change in Numeric Rating Scales (NRS) Score — -1.89 units on a scale
Phase 4 N=40 Harmonic ACE®+7 Shears in Laparoscopic Hysterectomy
Benign Disease Where Total Hysterectomy is Indicated
Primary: Percentage of Subjects Achieving Hemostasis at the Named Vessel/Pedicle (UA or UP) on the Left Side. — 97.5 percentage of participants
N/A N=38 Reducing Sedentary Behavior vs. Increasing Physical Activity in Older Adults
Sedentary Lifestyle
Primary: Change in Objectively Monitored Sedentary Behavior — -0.1; 0.6 hours/day
N/A N=35 Validation of Near-infrared Light Transillumination for Interproximal Enamel Caries Detection
Dental Caries
Primary: Caries Extension According to Diagnocam Codes 0-4 (Intra- and Interrater-Reliability, Sensitivity and Specificity) — 0.68; 0.87; 0.62; 0.76 weighted Kappa
Phase 3 N=10 Validation of the AVAPS AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD) Patients
COPD · OSA
Primary: Control of Nocturnal Hypoventilation — 6.5; 6.7 kPa
Phase 4 N=8 Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.
Rheumatoid Arthritis
Primary: Change From Baseline in the Ritchey-Camp Articular Index — 10.25; 9 joints
N/A N=90 Automated Fetal Femur Length Measurement by Five-Dimensional Ultrasound
Automated Fetal Femur Length Measurement by Five-Dimensional Ultrasound
Primary: Gestational Age Calculated by Accurate Dates of the Last Menstrual Period — 35.6 weeks
Phase 2 N=18 Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
Cardiac Allograft Vasculopathy
Primary: Insulin Levels Area Under Curve(AUC) — -47.7; 10.7 h*pmol/L
Phase 4 N=64 Mask Leak With Nasal Cannula in Noninvasive Positive Pressure Ventilation
Mechanical Ventilation Pressure High
Primary: Face Mask Leak Measured in Liters Per Minute by the Noninvasive Positive Pressure Ventilation Machine — 0; 0 Liters per minute